Globus Medical, Inc. (GMED)

Market Cap	11.22B
Revenue (ttm)	2.77B
Net Income (ttm)	423.78M
Shares Out	133.84M
EPS (ttm)	3.08
PE Ratio	27.22
Forward PE	21.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	942,445
Open	82.53
Previous Close	83.99
Day's Range	81.10 - 84.20
52-Week Range	51.79 - 94.93
Beta	1.12
Analysts	Buy
Price Target	89.09 (+6.3%)
Earnings Date	Nov 6, 2025

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 3, 2012
• Employees: 5,300
• Stock Exchange: NYSE
• Ticker Symbol: GMED
• Website: https://www.globusmedical.com

Financial Performance

In 2024, Globus Medical's revenue was $2.52 billion, an increase of 60.62% compared to the previous year's $1.57 billion. Earnings were $102.98 million, a decrease of -16.19%.

Analyst Summary

According to 14 analysts, the average rating for GMED stock is "Buy." The 12-month stock price target is $89.09, which is an increase of 6.30% from the latest price.

Price Target

$89.09

(6.30% upside)

Analyst Consensus: Buy